Bibliography
Nopp, A., Halldén, G., Lundahl, J., Johansson, E., Vrtala, S., Valenta, R., Grönneberg, R., & van Hage-Hamsten, M. (2000). Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen Bet v 1 and to recombinant Bet v 1 wild type in skin chamber fluids collected from birch pollenâallergic patients. Journal of Allergy and Clinical Immunology, 106(1), 101â109.
References
37
Referenced
39
10.1111/j.1398-9995.1989.tb04169.x
/ Allergy / IgE and IgG antibodies of patients with allergy to birch pollen as tools to define the allergen profile of Betula verrucosa by Jarolim (1989)10.1159/000237561
/ Int Arch Allergy Immunol / Different profiles in specific IgE to rBet v 1 and rBet v 2 in patients allergic to birch pollen from six countries by Elfman (1997)10.1002/j.1460-2075.1989.tb03597.x
/ EMBO J / The gene coding for the major birch pollen allergen, Bet v 1, is highly homologous to a pea diseases resistance response gene by Breiteneder (1989)10.1172/JCI119330
/ J Clin Invest / Conversion of the major birch pollen allergen, Bet v 1, into two non-anaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy by Vrtala (1997)10.1159/000024075
/ Int Arch Allergy Immunol / Genetic engineering of recombinant hypoallergenic oligomers of the major pollen allergen, Bet v 1: candidates for specific immunotherapy by Vrtala (1999)10.1016/S0091-6749(99)70077-1
/ J Allergy Clin Immunol by van Hage-Hamsten (1999)- Pauli G, Purohit A, Oster J-P, De Blay F, Vrtala S, Niederberger V, et al. Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wildtype by skin prick and intradermal testing: results obtained in a French population. Clin Exp Allergy. In press.
10.1136/pgmj.70.826.536
/ Postgrad Med J / Eosinophils in the 1990s: new perspectives on their role in health and disease by Wardlaw (1994){'key': '10.1067/mai.2000.106924_bib9', 'first-page': '373', 'article-title': 'Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions', 'volume': '131', 'author': 'De Monchy', 'year': '1985', 'journal-title': 'Am Rev Respir Dis'}
/ Am Rev Respir Dis / Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions by De Monchy (1985)10.1164/ajrccm/147.5.1126
/ Am Rev Respir Dis / Cellular and biochemival analysis of induced sputum from asthmatic and from healthy subjects by Fahy (1993)10.1164/ajrccm.154.1.8680684
/ Am J Respir Crit Care Med / Cellular infiltration of the airways of varying severity by Synek (1999){'key': '10.1067/mai.2000.106924_bib12', 'first-page': '281', 'article-title': 'CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines', 'volume': '80', 'author': 'Hartnell', 'year': '1993', 'journal-title': 'Immunology'}
/ Immunology / CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines by Hartnell (1993)10.1016/0091-6749(92)90068-D
/ J Allergy Clin Immunol / In vivo expression on lung eosinophils in eosinophilic pneumonia: CD69 as a possible activation marker for eosinophils by Nishikawa (1992)10.1016/S0091-6749(96)70270-1
/ J Allergy Clin Immunol / Anti-IgE-induced accumulation of leukocytes, mediators, and albumin in skin chamber fluid from healthy and atopic subjects by Raud (1996)10.1046/j.1365-2222.1999.00572.x
/ Clin Exp Allergy / Characterisation of eosinophils and detection of eotaxin in skin chamber fluid after challenge with relevant allergen in patients with mild asthma by Fernvik (1999)10.1006/prep.1996.0671
/ Protein Expr Purif / High-level expression and purification of the major birch pollen allergen, Bet v 1 by Hoffmann-Sommergruber (1997)10.1016/0022-1759(89)90191-9
/ J Immunol Meth / A new membrane permeabilization method for the detection of intracellular antigens by flow cytometry by Halldén (1989)10.1111/j.1398-9995.1993.tb04707.x
/ Allergy / Counts of activated blood eosinophils for monitoring asthma by Hed (1993){'key': '10.1067/mai.2000.106924_bib19', 'first-page': '455', 'article-title': 'Allergen induced accumulation of eosinophils and lymphocytes in skin chambers is associated with increased levels of IL-4 and sVCAM-1', 'volume': '54', 'author': 'Fernvik', 'year': '1999', 'journal-title': 'Allergy'}
/ Allergy / Allergen induced accumulation of eosinophils and lymphocytes in skin chambers is associated with increased levels of IL-4 and sVCAM-1 by Fernvik (1999)10.1165/ajrcmb.21.3.f160
/ Am J Respir Cell Mol Biol / Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissue by Rothenberg (1999)10.1038/309182a0
/ Nature / Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein by Tai (1984)10.1002/jlb.66.3.447
/ J Leukoc Biol / Reactivity of monoclanal antibodies EG1 and EG2 with eosinophils and their granule proteins by Nakajima (1999){'key': '10.1067/mai.2000.106924_bib23', 'first-page': '250', 'article-title': 'Eosinophil activity reflects clinical status in patients with asthma before and during a predisolone course', 'volume': '75', 'author': 'Skedinger', 'year': '1995', 'journal-title': 'Ann Allergy Asthma Immunol'}
/ Ann Allergy Asthma Immunol / Eosinophil activity reflects clinical status in patients with asthma before and during a predisolone course by Skedinger (1995)10.1111/j.1398-9995.1996.tb04450.x
/ Allergy / The degree of natural allergen exposure modifies eosinophil activity markers in the circulation of patients with mild asthma by Fernvik (1996)10.1016/S1081-1206(10)62839-6
/ Ann Allergy Asthma Immunol / Conditions in blood sampling conditions that extend the ex vivo stability of eosinophil activity markers in peripheral blood from allergic patients and healthy controls by Halldén (1999)10.1023/A:1006940109869
/ Inflammation / The impact of eotaxin- and IL5-induced adhesion and transmigration of eosinophil activity markers by Fernvik (2000)10.1034/j.1398-9995.2000.00363.x
/ Allergy / Quantitative, rather than qualitative, differences in CD69 upregulation in human blood eosinophils upon activation with selected stimuli by Nopp (2000)10.1007/s000110050383
/ Inflamm Res / The effect of in vitro activation and platelet interaction on the CD9 distribution and adhesion properties of human eosinophils by Fernvik (1999)10.1084/jem.174.3.745
/ J Exp Med / Granulocyte/machrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils by Kita (1991)10.1136/thx.54.9.825
/ Thorax / Cytokines in asthma by Chung (1999)10.4049/jimmunol.155.10.4939
/ J Immunol / Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product by Moqbel (1995)10.1016/S0091-6749(95)70037-4
/ J Allergy Clin Immunol / Expression of interleukin-4 and interleukin-5 mRNA in developing cutaneous late phase reactions by Vowels (1995)10.1016/S0091-6749(97)70201-X
/ J Allergy Clin Immunol / Cytokine levels and inflammatory responses in developing late-phase reactions in the skin by Zweiman (1997)10.1016/S0091-6749(98)70248-9
/ J Allergy Clin Immunol / Immunohistochemical detection of human basophils in late-phase skin reactions by Irani (1998)10.4049/jimmunol.146.2.671
/ J Immunol / Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen by Charlesworth (1991)10.4049/jimmunol.163.7.3976
/ J Immunol by Ying (1999)10.1016/S0091-6749(95)70192-3
/ J Allergy Clin Immunol / Chronologic analysis of in situ cytokine expression in mite allergen–induced dermatitis in atopic subjects by Yamada (1995)
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 25, 2002, 12:20 a.m.) |
Deposited | 2 years, 4 months ago (April 3, 2023, 11:12 a.m.) |
Indexed | 1 year ago (Aug. 29, 2024, 9:50 a.m.) |
Issued | 25 years, 2 months ago (July 1, 2000) |
Published | 25 years, 2 months ago (July 1, 2000) |
Published Print | 25 years, 2 months ago (July 1, 2000) |
@article{Nopp_2000, title={Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen Bet v 1 and to recombinant Bet v 1 wild type in skin chamber fluids collected from birch pollen–allergic patients}, volume={106}, ISSN={0091-6749}, url={http://dx.doi.org/10.1067/mai.2000.106924}, DOI={10.1067/mai.2000.106924}, number={1}, journal={Journal of Allergy and Clinical Immunology}, publisher={Elsevier BV}, author={Nopp, Anna and Halldén, Gunilla and Lundahl, Joachim and Johansson, Eva and Vrtala, Susanne and Valenta, Rudolf and Grönneberg, Reidar and van Hage-Hamsten, Marianne}, year={2000}, month=jul, pages={101–109} }